/QIPT
QIPT Stock - Quipt Home Medical Corp.
Healthcare|Medical - DevicesNASDAQ
$3.52+0.28%
+$0.01 (+0.28%) • Dec 19
74
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.94
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).57
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+3.7%upside
Target: $3.65
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for QIPT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.48 – $3.56
TARGET (TP)$3.65
STOP LOSS$3.24
RISK/REWARD1:0.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.49
52W High$3.54
52W Low$1.35
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $245.36M | $245.91M | $211.68M | $139.86M | $102.35M |
| Gross Profit | $239.31M | $176.99M | $153.78M | $106.65M | $74.18M |
| Gross Margin | 97.5% | 72.0% | 72.6% | 76.3% | 72.5% |
| Operating Income | $-3,823,000 | $1.11M | $5.76M | $4.73M | $-1,460,000 |
| Net Income | $-10,580,000 | $-6,763,000 | $-2,784,000 | $4.84M | $-6,174,000 |
| Net Margin | -4.3% | -2.8% | -1.3% | 3.5% | -6.0% |
| EPS | $-0.24 | $-0.16 | $-0.07 | $0.14 | $-0.20 |
Company Overview
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
33%
Hold / Neutral
1
33%
Sell / Underperform
1
33%
Analyst Consensus🔴 Bearish
1 Bullish2 Neutral/Bearish
Price Targets
$6
Average Target
↑ 80.4% Upside
Now
$2
Low
$6
Average
$11
High
Based on 2 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 14th 2025 | Canaccord Genuity | Downgrade | Hold | $1.7 |
| May 17th 2024 | Raymond James | Downgrade | Underperform | - |
| February 16th 2024 | Raymond James | Downgrade | Market Perform | - |
| June 14th 2023 | Canaccord Genuity | Resumed | Buy | $11 |
Earnings History & Surprises
QIPTBeat Rate
22%
Last 18 quarters
Avg Surprise
-236.3%
EPS vs Estimate
Beats / Misses
4/13
1 met exactly
Latest EPS
$-0.08
Q4 2025
EPS Surprise History
Q1 24
-498.8%
$-0.01vs$-0.00
Q2 24
-549.4%
$-0.03vs$-0.00
Q3 24
-166.7%
$-0.04vs$-0.01
Q4 24
-250.0%
$-0.07vs$-0.02
Q1 25
+25.0%
$-0.03vs$-0.04
Q2 25
-450.0%
$-0.07vs$0.02
Q3 25
-2.1%
$-0.07vs$-0.07
Q4 25
-152.6%
$-0.08vs$-0.03
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 9, 2026 | — | — | — | — |
Q4 2025 | Dec 15, 2025 | $-0.03 | $-0.08 | -152.6% | ✗ MISS |
Q3 2025 | Aug 11, 2025 | $-0.07 | $-0.07 | -2.1% | ✗ MISS |
Q2 2025 | May 12, 2025 | $0.02 | $-0.07 | -450.0% | ✗ MISS |
Q1 2025 | Feb 10, 2025 | $-0.04 | $-0.03 | +25.0% | ✓ BEAT |
Q4 2024 | Dec 16, 2024 | $-0.02 | $-0.07 | -250.0% | ✗ MISS |
Q3 2024 | Aug 14, 2024 | $-0.01 | $-0.04 | -166.7% | ✗ MISS |
Q2 2024 | May 15, 2024 | $-0.00 | $-0.03 | -549.4% | ✗ MISS |
Q1 2024 | Feb 14, 2024 | $-0.00 | $-0.01 | -498.8% | ✗ MISS |
Q4 2023 | Dec 18, 2023 | $-0.00 | $-0.03 | -849.4% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.00 | $-0.03 | -1696.4% | ✗ MISS |
Q2 2023 | May 15, 2023 | $0.07 | $-0.02 | -128.6% | ✗ MISS |
Q1 2023 | Feb 13, 2023 | $0.01 | $0.01 | 0.0% | = MET |
Q4 2022 | Dec 21, 2022 | $0.01 | $0.05 | +249.9% | ✓ BEAT |
Q3 2022 | Aug 15, 2022 | $0.07 | $0.00 | -94.9% | ✗ MISS |
Q2 2022 | May 16, 2022 | $0.03 | $0.14 | +366.7% | ✓ BEAT |
Q1 2022 | Jan 27, 2022 | $-0.01 | $-0.02 | -220.0% | ✗ MISS |
Q4 2021 | Dec 28, 2021 | $-0.01 | $-0.04 | -254.1% | ✗ MISS |
Q3 2021 | Aug 23, 2021 | $0.00 | $0.02 | +418.1% | ✓ BEAT |
Latest News
Canaccord Genuity Maintains Hold on Quipt Home Medical, Raises Price Target to $3.65
➖ NeutralBenzinga•Dec 17, 2025, 07:34 PM•Also:
Quipt Home Medical shares are trading higher after the company reported better-than-expected Q4 sales results. The company announced it will be acquired by a special purpose acquisition vehicle.
📈 PositiveBenzinga•Dec 15, 2025, 03:16 PM
Quipt Home Medical Announced That It Has Entered Into A Definitive Agreement To Be Acquired By A Special Purpose Acquisition Vehicle For $3.65 Per Share
📈 PositiveBenzinga•Dec 15, 2025, 12:39 PM
Quipt Home Medical Q4 EPS $(0.08) Misses $(0.03) Estimate, Sales $68.300M Beat $63.416M Estimate
➖ NeutralBenzinga•Dec 15, 2025, 12:34 PM
Lakeview, A Shareholder Of Quipt Home Medical, Criticizes Board For Undermining $3.10 Buyout Offer For Failing To Engage In Good Faith With A Credible Bidder As Part Of A Transparent And Viable Strategic Review
📉 NegativeBenzinga•Oct 22, 2025, 04:13 PM
Forager Capital Says Quipt's Convenient Omissions, Lawsuit Demonstrate Board Is Motivated By Self-Serving Tactics Rather Than Shareholders' Best Interests; Reaffirms $3.10 Offer And Signals Willingness To Improve With Constructive Engagement
📉 NegativeBenzinga•Sep 3, 2025, 12:37 PM
QIPT stock has given up its prior gain. Quipt Home Medical shares were trading higher after the company acquired 60% ownership in Hart Medical, boosting its annualized run-rate revenue to over $300M.
➖ NeutralBenzinga•Sep 3, 2025, 12:19 PM
Quipt Home Medical shares are trading higher after the company acquired 60% ownership in Hart Medical, boosting its annualized run-rate revenue to over $300M.
📈 PositiveBenzinga•Sep 3, 2025, 11:33 AM
Quipt Home Medical Completes Acquisition of 60% Ownership In Hart Medical; Quipt Says Annualized Run-Rate Revenue Now Over $300M
📈 PositiveBenzinga•Sep 3, 2025, 11:33 AM
Quipt Home Medical Confirms Receipt Of Repeat $3.10/Shr Proposal From Forager Capital
➖ NeutralBenzinga•Aug 27, 2025, 11:38 AM
Forager Capital proposes buyout of Quipt Home Medical; shares up 22%
📈 PositiveSeeking Alpha•Aug 25, 2025, 01:07 PM
Quipt Home Medical shares are trading higher after Forager Capital Management submitted a proposal to acquire all outstanding shares for $3.10 per share in cash.
📈 PositiveBenzinga•Aug 25, 2025, 12:32 PM
Forager Capital Management Submits Proposal To Acquire All Outstanding Shares Of Quipt Home Medical For $3.10/Share In Cash
📈 PositiveBenzinga•Aug 25, 2025, 12:32 PM
Canaccord Genuity Maintains Hold on Quipt Home Medical, Raises Price Target to $2.3
➖ NeutralBenzinga•Aug 19, 2025, 02:09 PM•Also:
Frequently Asked Questions about QIPT
What is QIPT's current stock price?
Quipt Home Medical Corp. (QIPT) is currently trading at $3.52 per share. The stock has moved +0.28% today.
What is the analyst price target for QIPT?
The average analyst price target for QIPT is $3.65, based on 1 analyst.
What sector is Quipt Home Medical Corp. in?
Quipt Home Medical Corp. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is QIPT's market cap?
Quipt Home Medical Corp. has a market capitalization of $0.15 billion, making it a small-cap company.
Does QIPT pay dividends?
No, Quipt Home Medical Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANEB
Anebulo Pharmaceuticals, Inc.
$2.17
Mkt Cap: $0.1B
APYX
Apyx Medical Corporation
$3.49
Mkt Cap: $0.1B
COYA
Coya Therapeutics, Inc.
$5.49
Mkt Cap: $0.1B
DCGO
DocGo Inc.
$0.89
Mkt Cap: $0.1B
FONR
FONAR Corporation
$14.94
Mkt Cap: $0.1B
HYPR
Hyperfine, Inc.
$1.10
Mkt Cap: $0.1B
NSPR
InspireMD, Inc.
$1.99
Mkt Cap: $0.1B
RCEL
AVITA Medical, Inc.
$3.46
Mkt Cap: $0.1B
VANI
Vivani Medical, Inc.
$1.39
Mkt Cap: $0.1B
XTNT
Xtant Medical Holdings, Inc.
$0.77
Mkt Cap: $0.1B
Explore stocks similar to QIPT for comparison